Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | RNF183 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RIC3 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | CTC-273B12.7 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | GATSL2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | CHRNB2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | SDK1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | ZMIZ1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |